---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-001912"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2023-01-06T23:59:59+00:00"
generated_at: "2026-06-20T18:47:30.407049+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health receives Nasdaq delisting notice for bid price below $0.10 for 10 days

## Summary
- Nasdaq notified Jaguar Health on Jan 5, 2023 that its common stock bid price closed below $0.10 for 10 consecutive trading days, triggering delisting under Rule 5810(c)(3)(A)(iii).
- Company intends to request a hearing before the Nasdaq Hearings Panel to appeal; request will stay delisting pending hearing and potential extension.
- Jaguar Health also must regain compliance with $1.00 minimum bid price rule by Feb 13, 2023, having been granted a 180-day grace period.
- Special stockholder meeting scheduled for Jan 20, 2023 to vote on reverse stock split (ratio of 1-for-3 to 1-for-75) to potentially regain compliance.

## SEC filing metadata
- accession: 0001104659-23-001912
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2023-01-06T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000110465923001912/0001104659-23-001912-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000110465923001912/tm232344d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-001912
- JSON: https://secwatch.observer/filing/0001104659-23-001912.json
- Plain text: https://secwatch.observer/filing/0001104659-23-001912.txt

## Key facts
- Listing & Compliance Notices
  Jaguar Health, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(3)(A)(iii)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5810(3)(A)(iii)
  source text: January 5, 2023, Jaguar Health, Inc. (the “Company”) received notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the bid price for the Company’s voting common stock, par value $0.0001 per share (the “Common Stock”), had closed below $0.10 per share for the preceding ten consecutive trading days, in contravention of Nasdaq Listing Rule 5810(3)(A)(iii) (the “$0.10 Rule”), the Company’s securities were subject to delisting unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”) to appea
  evidence_url: https://www.sec.gov/Archives/edgar/data/1585608/000110465923001912/0001104659-23-001912-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.